Cite
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.
MLA
Johnson, Amber M., et al. “Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.” Journal of Immunology, vol. 204, no. 8, Apr. 2020, pp. 2295–307. EBSCOhost, https://doi.org/10.4049/jimmunol.1900778.
APA
Johnson, A. M., Bullock, B. L., Neuwelt, A. J., Poczobutt, J. M., Kaspar, R. E., Li, H. Y., Kwak, J. W., Hopp, K., Weiser-Evans, M. C. M., Heasley, L. E., Schenk, E. L., Clambey, E. T., & Nemenoff, R. A. (2020). Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma. Journal of Immunology, 204(8), 2295–2307. https://doi.org/10.4049/jimmunol.1900778
Chicago
Johnson, Amber M., Bonnie L. Bullock, Alexander J. Neuwelt, Joanna M. Poczobutt, Rachael E. Kaspar, Howard Y. Li, Jeff W. Kwak, et al. 2020. “Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.” Journal of Immunology 204 (8): 2295–2307. doi:10.4049/jimmunol.1900778.